CPOINT Capital Corp. Announces Changes to Holdings in Conavi Medical Corp.
News Source : Financial Post
News Summary
- CPOINT Capital Corp
- and its affiliate Juno Pharmaceuticals LP (“Juno”) acquired 1,875,000 common shares in the capital of Conavi Medical Corp
- CPOINT and Juno purchased the Common Shares at a price of $0
- 40 per Common Share for total consideration of $750,000
TORONTO, April 25, 2025 (GLOBE NEWSWIRE) CPOINT Capital Corp. (CPOINT) announces that, on April 23, 2025, it and its affiliate Juno Pharmaceuticals LP (Juno) acquired 1,875,000 common shares (the Com [+4456 chars]